Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDHaemonetics Corp. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 8 | $1.25 | $1.30 | $1.27 |
| Q2 2026 | 8 | $1.03 | $1.14 | $1.08 |
| Q3 2026 | 8 | $1.23 | $1.35 | $1.29 |
| Q4 2026 | 8 | $1.26 | $1.41 | $1.35 |
| Q1 2027 | 5 | $1.48 | $1.55 | $1.51 |
| Q2 2027 | 3 | $1.30 | $1.36 | $1.32 |
| Q3 2027 | 5 | $1.40 | $1.46 | $1.43 |
| Q4 2027 | 3 | $1.47 | $1.54 | $1.50 |
| Q1 2028 | 6 | $1.51 | $1.58 | $1.54 |
| Q2 2028 | 4 | $1.42 | $1.48 | $1.45 |
| Q3 2028 | 6 | $1.62 | $1.69 | $1.65 |
| Q4 2028 | 4 | $1.69 | $1.76 | $1.72 |
| Q1 2029 | 5 | $1.66 | $1.73 | $1.69 |
Haemonetics Corp. Earnings Date And Information
Haemonetics Corp. last posted its earnings results on Thursday, August 6th, 2026. The company reported $1.14 earnings per share for the quarter, topping analysts' consensus estimates of $1.08 by $0.06. The company had revenue of 339.38 M for the quarter and had revenue of 1.33 B for the year. Haemonetics Corp. has generated $2 earnings per share over the last year ($2.05 diluted earnings per share) and currently has a price-to-earnings ratio of 52.82. Haemonetics Corp. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Haemonetics Corp. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/06/2026 | Q1 2027 | $1.08 | $0.73 | -0.35 | $327.86 M | $339.38 M |
| 05/20/2026 | Q4 2026 | N/A | -$0.44 | N/A | $336.83 M | $346.35 M |
| 02/05/2026 | Q3 2026 | $1.27 | $0.96 | -0.31 | $331.92 M | $338.97 M |
| 11/06/2025 | Q2 2026 | $1.12 | $0.81 | -0.31 | $311.51 M | $327.32 M |
| 08/07/2025 | Q1 2026 | $1.01 | $0.71 | -0.3 | $301.79 M | $321.39 M |
| 05/21/2025 | Q4 2025 | N/A | $1.17 | N/A | $329.36 M | $330.60 M |
| 02/06/2025 | Q3 2025 | $1.18 | $0.75 | -0.43 | $352.72 M | $348.54 M |
| 11/07/2024 | Q2 2025 | $1.09 | $0.66 | -0.43 | $342.57 M | $345.51 M |
| 08/08/2024 | Q1 2025 | $1.03 | $0.75 | -0.28 | $335.08 M | $336.17 M |
| 05/20/2024 | Q4 2024 | N/A | $0.40 | N/A | $329.53 M | $343.29 M |
| 02/08/2024 | Q3 2024 | $0.97 | $0.62 | -0.35 | $320.84 M | $336.25 M |
| 11/02/2023 | Q2 2024 | $0.94 | $0.49 | -0.45 | $313.15 M | $318.18 M |
| 08/08/2023 | Q1 2024 | $0.73 | $0.81 | 0.08 | $292.74 M | $311.33 M |
| 05/22/2023 | Q4 2023 | N/A | $0.58 | N/A | $290.79 M | $304.42 M |
| 02/07/2023 | Q3 2023 | $0.79 | $0.65 | -0.14 | $299.56 M | $305.30 M |
| 11/08/2022 | Q2 2023 | N/A | $0.65 | N/A | $269.22 M | $297.49 M |
| 08/10/2022 | Q1 2023 | $0.53 | $0.39 | -0.14 | $249.00 M | $261.46 M |
| 05/25/2022 | Q4 2022 | N/A | $0.19 | N/A | $257.11 M | $265.00 M |
| 02/08/2022 | Q3 2022 | $0.75 | $0.45 | -0.3 | $265.39 M | $259.77 M |
| 11/09/2021 | Q2 2022 | $0.63 | $0.29 | -0.34 | $240.84 M | $239.90 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Haemonetics Corp. Earnings: FAQ's
In the previous quarter, Haemonetics Corp. (:HAE) reported $1.14 earnings per share (EPS) to beat the analysts' consensus estimate of $1.08 by $0.06.
The conference call for Haemonetics Corp.'s latest earnings report can be listened to online.
The conference call transcript for Haemonetics Corp.'s latest earnings report can be read online.
Haemonetics Corp. (:HAE) has a recorded annual revenue of $1.33 B.
Haemonetics Corp. (:HAE) has a recorded net income of $97.31 M.Haemonetics Corp. has generated $2.05 earnings per share over the last four quarters.
Haemonetics Corp. (:HAE) has a price-to-earnings ratio of 52.82 and price/earnings-to-growth ratio is -1.41.